Daily Briefing for October 6, 2026

Utah lets AI write first acne prescriptions; CommonSpirit credits AI with $200 million; most pathology AI lacks public data; AI intake beats eye residents

The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source.

Read the post and its sources

Utah approved a pilot Oct. 5 that lets Nolla Health's software issue first-time prescriptions for acne, with physicians reviewing each prescription in advance only for the first 100 patients, MobiHealthNews reported.

The state's earlier sandbox pilots let AI renew existing prescriptions; Nolla's is the first to let AI start a treatment, according to Becker's. STAT reported that Utah also plans to require third-party audits of the claims companies make in its AI sandbox.

Elsewhere, CommonSpirit Health's chief financial officer told investors the system has captured $200 million in financial value from AI. A Helsinki review found no public performance data for 61% of authorized AI products in pathology and hematology morphology, and a randomized trial in China found a language model agent took more complete eye-clinic histories than ophthalmology residents.

In this episode

• Utah lets Nolla Health's AI issue first-time acne prescriptions from a physician-approved list of topical drugs
• CommonSpirit says AI has produced $200 million in financial value while AI spending stays under 0.75% of its IT budget
• No public performance data found for 47 of 77 authorized pathology and hematology AI products, Helsinki review finds
• Language model agent takes fuller eye-clinic histories than ophthalmology residents in 172-patient randomized trial